Earnings call LifeVantage reported Q4 FY2025 revenue of $55.1M, up 12.6% YoY, with gross margin expanding 40 bps to 79.9%. Adjusted EBITDA remained flat at $4.8M. The company announced the acquisition ...

Q4 2025 Earnings Call Transcript September 4, 2025 LifeVantage Corporation reports earnings inline with expectations. Reported EPS is $0.17 EPS, expectations were $0.17. Operator: Good day, ladies and ...

LifeVantage Corporation (LFVN) reported its fourth-quarter 2025 earnings, revealing a positive surprise in earnings per share (EPS) that exceeded analyst expectations. The company announced an EPS of ...

LifeVantage Corporation, the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our ...

SALT LAKE CITY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the ...

SALT LAKE CITY - LifeVantage Corporation (NASDAQ:LFVN), a $171 million market cap company with impressive 80% gross margins and "GREAT" financial health according to InvestingPro, announced Wednesday ...

SALT LAKE CITY, Sept. 02, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the ...

Ferroptosis, an iron-dependent form of regulated cell death characterized by lipid peroxidation, has emerged as a pivotal mechanism in bone disorders including osteoporosis and osteonecrosis. The ...